Pharma Company Cephalon Has "Sensational" 2008
Pharma Company Cephalon Has "Sensational" 2008
SUGAR LAND--February 16, 2009--Researched by Industrial Info Resources (Sugar Land, Texas)--Finding a CEO that can honestly say of his or her company that "2008 was a sensational year," is quite refreshing. These words were spoken by Frank Baldino, CEO of pharmaceutical company Cephalon Incorporated (NASDAQ:CEPH) (Frazer, Pennsylvania) during a recent conference call regarding the company's earnings for the 2008 fiscal year. The company was one of only 25 companies listed in Standard & Poor's S&P 500 index whose share price appreciated in 2008.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
- Turner Construction Involved in More than $24 Billion Worth of U.S. Project...
- Medical Devices & Equipment Sector Brings Billions in Spending to the U.S.